摘要
目的观察依匹斯汀联合转移因子治疗慢性荨麻疹的疗效。方法将200例慢性荨麻疹患者随机分为两组,治疗组102例,对照组98例。两组均口服依匹斯汀20 mg,每天1次,同时治疗组联合口服转移因子6 mg,每天2次,两组疗程均为4周。结果治疗结束后,治疗组有效率为61.76%,对照组有效率为37.76%,两组疗效比较差异有统计学意义(P<0.05)。结论依匹斯汀联合转移因子治疗慢性荨麻疹安全有效,其疗效优于单用依匹斯汀治疗。
Objective To observe the efficacy of epinastine combined with transfer factor in the treatment of chronic urticaria.Methods 200 cases with chronic urticaria were divided into two groups randomly.Patients in the treatment group and the control group were given epinastine 20 mg once daily for 4 weeks.At the same time,the patients in the treatment group were given transfer factor 6 mg twice daily.Results At the end of treatment,the response rates were 61.76% and 37.76% respectively.There was significant difference between the treatment group and the control group.Conclusion Epinastine combined with transfer factor is more effective than epinastine alone in the treatment of chronic urticaria.
出处
《重庆医学》
CAS
CSCD
北大核心
2010年第23期3223-3223,3230,共2页
Chongqing medicine
关键词
荨麻疹
慢性病
依匹斯汀
转移因子
urticaria
chronic disease
epinastine
transfer factor
